VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Northrop Grumman Corporation vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Northrop Grumman Corporation
NOC · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Northrop Grumman Corporation's moat claims, evidence, and risks.
View NOC analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 72 / 100 for Northrop Grumman Corporation).
- Segment focus: Northrop Grumman Corporation has 4 segments (28.7% in Aeronautics Systems); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Northrop Grumman Corporation has 6 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Northrop Grumman Corporation
Aeronautics Systems
Military aircraft systems (manned & unmanned) plus sustainment/modernization
Global (primarily United States and allies)
U.S. government and allied governments
Prime contractor and major subsystem supplier
28.7%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Northrop Grumman Corporation strengths
Novo Nordisk A/S strengths
Segment mix
Northrop Grumman Corporation segments
Full profile >Aeronautics Systems
Oligopoly
Defense Systems
Oligopoly
Mission Systems
Oligopoly
Space Systems
Oligopoly
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.